[15] S. Maddila, S.K. Avula, A.K. Avula, P. Lavanya, Efficient organocatalytic multicomponent synthesis of
(α-aminoalkyl)phosphonates, Arabian Journal of Chemistry, 9 (2016) 787-791.
[16] S. Maddila, S.B. Jonnalagadda, Synthesis and Biological Activity of Ethyl 2-(substituted benzylthio)-4-
(3′-(ethoxycarbonyl)biphenyl-4-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylate Derivatives, Archiv der
Pharmazie, 345 (2011) 163-168.
[17] S. Maddila, S.B. Jonnalagadda, Synthesis and antimicrobial activity of new 1,3,4-thiadiazoles
containing oxadiazole, thiadiazole and triazole nuclei, Pharmaceutical Chemistry Journal, 46 (2013) 661-
666.
[18] S. Maddila, S.B. Jonnalagadda, New Class of Pyrimidinesulfamoyl Containing Pyrazole and Pyrrole
Derivatives and Their Antioxidant Activity, Letters in Organic Chemistry, 10 (2013) 374-379.
[19] Shamsuzzaman, A.M. Dar, Y. Khan, A. Sohail, Synthesis and biological studies of steroidal pyran based
derivatives, Journal of Photochemistry and Photobiology B: Biology, 129 (2013) 36-47.
[20] E.F. Martin, A.T. Mbaveng, M.H. de Moraes, V. Kuete, M.W. Biavatti, M. Steindel, T. Efferth, L.P.
Sandjo, Prospecting for cytotoxic and antiprotozoal 4-aryl-4H-chromenes and 10-aryldihydropyrano[2,3-
f]chromenes, Archiv der Pharmazie, 351 (2018) 1800100.
[21] S.A. Abdelatef, M.T. El-Saadi, N.H. Amin, A.H. Abdelazeem, H.A. Omar, K.R.A. Abdellatif, Design,
synthesis and anticancer evaluation of novel spirobenzo[h]chromene and spirochromane derivatives with
dual EGFR and B-RAF inhibitory activities, European Journal of Medicinal Chemistry, 150 (2018) 567-578.
[22] R.M. Mohareb, M.Y. Zaki, N.S. Abbas, Synthesis, anti-inflammatory and anti-ulcer evaluations of
thiazole, thiophene, pyridine and pyran derivatives derived from androstenedione, Steroids, 98 (2015) 80-
91.
[23] Y. Thur, A. Bhalerao, Z. Munshi, N. Pansare, K. Mann, G. Hanauer, H.-P. Kley, S. Nappe, C. Weiss-Haljiti,
C. Ostermann, C. Zitt, M. Schaefer, D. Mondal, A. Ali Siddiki, V. Armugam, V. Gudaghe, M. Gupta, P.
Rayudu, F.M. Dautzenberg, K. Das Sarma, Structure–activity relationships of 2-arylamido-5,7-dihydro-4H-
thieno[2,3-c]pyran-3-carboxamide derivatives as cannabinoid receptor agonists and their analgesic
action, Bioorganic & Medicinal Chemistry Letters, 22 (2012) 7314-7321.
[24] M.D. Aytemir, Ü. Çaliş, M. Özalp, Synthesis and Evaluation of Anticonvulsant and Antimicrobial
Activities of 3-Hydroxy-6-methyl-2-substituted 4H-Pyran-4-one Derivatives, Archiv der Pharmazie, 337
(2004) 281-288.
[25] M. Di Braccio, G. Grossi, G. Roma, C. Marzano, F. Baccichetti, M. Simonato, F. Bordin, Pyran
derivatives: Part XXI. Antiproliferative and cytotoxic properties of novel N-substituted 4-aminocoumarins,
their benzo-fused derivatives, and some related 2-aminochromones, Il Farmaco, 58 (2003) 1083-1097.
[26] J.A. Makawana, D.C. Mungra, M.P. Patel, R.G. Patel, Microwave assisted synthesis and antimicrobial
evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus, Bioorganic & Medicinal
Chemistry Letters, 21 (2011) 6166-6169.
[27] J.A. Makawana, M.P. Patel, R.G. Patel, Synthesis and Antimicrobial Evaluation of New Pyrano[4,3-
b]pyran and Pyrano[3,2-c]chromene Derivatives Bearing a 2-Thiophenoxyquinoline Nucleus, Archiv der
Pharmazie, 345 (2011) 314-322.
[28] H. Sheibani, M. Babaie, Three-Component Reaction to Form 1,4-Dihydropyrano[2,3-c]pyrazol-5-yl
Cyanides, Synthetic Communications, 40 (2009) 257-265.
[29] G. Vasuki, K. Kumaravel, Rapid four-component reactions in water: synthesis of pyranopyrazoles,
Tetrahedron Letters, 49 (2008) 5636-5638.
[30] S. Banerjee, A. Horn, H. Khatri, G. Sereda, A green one-pot multicomponent synthesis of 4H-pyrans
and polysubstituted aniline derivatives of biological, pharmacological, and optical applications using silica
nanoparticles as reusable catalyst, Tetrahedron Letters, 52 (2011) 1878-1881.
[31] N. Seshu Babu, N. Pasha, K.T. Venkateswara Rao, P.S. Sai Prasad, N. Lingaiah, A heterogeneous strong
basic Mg/La mixed oxide catalyst for efficient synthesis of polyfunctionalized pyrans, Tetrahedron Letters,
49 (2008) 2730-2733.